Another example is TP53 mutations; it was demonstrated that lincRNA-p21 and NEAT1 are targets of the p53 protein and that they induce apoptosis upon DNA damage in primary CLL cells, but only in the TP53 wild-type setting [20]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.